Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To assess the immune response, SBA will be performed against the N. meningitidis serogroup B indicator strains H44/76, NZ98/254 and 5/99 at one month after a vaccination course of two doses of rMenB + OMV NZ administered two months apart.
Critère d'inclusion
- A Phase 3b, Single-Center, Open-label Study to Assess the Immunogenicity and Safety of Novartis Meningococcal B Recombinant Vaccine When Administered at a 0, 2-Month Schedule in Healthy at-Risk Adults Aged 18 to 65 Years inclusive